Timely access to treatment is critical for individuals dealing with any number of medical conditions. Metastatic breast cancer is no exception to this. Metastatic breast cancer (MBC) is breast cancer that has spread from the breast to another part of the body, most often the bones, lungs, liver or brain. The average life expectancy of an individual with MBC is three years.
Although there is no cure, treatments have extended survival for women and men with MBC. But for some individuals dealing with MBC, not being able to work, and thus not having health insurance, presents a major problem in getting access to care. Continue reading
Over the years, October has become a marketing opportunity for companies that splash pink on their products, suggesting to consumers that they’re helping the breast cancer cause by buying these products. Unfortunately, most of the time very little of the money paid for these products actually goes to breast cancer-related charities. And some of the companies that make these products also produce toxic chemicals that may contribute to an increased risk of breast cancer, Breast Cancer Action explains in their 
One of the stories that has stood out over the last few years in breast cancer treatment was the FDA’s approval in 2015 of the drug palbociclib (Ibrance) for treatment of hormone receptor-positive metastatic breast cancer (MBC). 
Learning about progress against cancer has been a main theme here on After Twenty Years since I started this blog about five years ago. One of my first posts in 2013 was a look back at 
Every two years, the American Cancer Society publishes a new report on breast cancer trends. The 
2016 was not a year for big breakthroughs in cancer research and improving access to quality care. And yet, it was a year in which many of the issues that need to be addressed if we want to ever see those breakthroughs were front and center.
What’s exciting in cancer research right now? In this post, I’ll review several of the most interesting cancer research stories that have been in the news this fall.
One of the best ways to help in the fight against cancer is by making a donation in support of cancer research. But deciding which organizations will make the most effective use of our contributions requires a little homework.
In a recent post, we looked at 
Many of us are interested in making donations in support of cancer research. But figuring out which organizations will make the most effective use of our contributions isn’t always an easy task. This post is the second in a series in which we’re looking at individual charities that focus primarily on cancer research.